Pharmaceutical Technology - January 2024

Pharmaceutical Technology - January 2024

Issue link: https://www.e-digitaleditions.com/i/1514991

Contents of this Issue

Navigation

Page 27 of 51

28 Pharmaceutical Technology ® Regulating Innovation, Quality, and Risk eBook January 2024 PharmTech.com Qualit y 2. ICH, Q9 Quality Risk Management, Step 4 version (2005). 3. ICH, Q9(R1) Quality Risk Management, Final concept paper (2020). 4. TechTarget, What is Systems Thinking? www.techtar- get.com/searchcio/definition/systems-thinking (accessed April 23, 2023). 5. ICH, Q10 Pharmaceutical Quality System, Step 4 version (2008). 6. Greene, A.; Lipa, M. J. Steps Towards Digital Transfor- mation in the Pharma Manufacturing Landscape— Knowledge-Enabled Technology Transfer. Level 3 2022, 17 (2) 1. 7. Cambridge Dictionary, Explicit Knowledge. dictionary. cambridge.org/ (accessed April 23, 2023). 8. APQC, Knowledge Management Glossary; APQC, 2022. 9. Kane, P. E.; Lipa, M. J. The House of Knowledge Ex- cellence—A Framework for Success. In A Lifecycle Approach to Knowledge Excellence in the Biopharmaceu- tical Industry, 1st ed.; Calnan, N.; Lipa, M. J.; Kane, P.; Menezes, J. C., Eds.; Taylor & Francis, 2018; pp. 181– 224. DOI: 10.1201/9781315368337 10. ICH, Quality Guidelines. www.ich.org/page/quali- ty-guidelines (accessed April 23, 2023). 11. ISO, Knowledge Management Systems—Requirements; ISO 30401:2018; ISO: Geneva, Switzerland, 2018. https://www.iso.org/standard/68683.html (accessed April 23, 2023). 12. Lipa, M. J.; O'Donnell, K.; Greene, A. Managing Knowl- edge and Risk—A Literature Review on the Interde- pendency of QRM and KM as ICH Q10 Enablers. Level 3 2020, 15 (2), 3. DOI: 10.21427/2jdq-jq09 13. ICH, Q13 Continuous Manufacturing of Drug Substances and Drug Products, Final version (2022). 14. ICH, Q14 Analytical Procedure Development, Draft ver- sion (2022). 15. Yu, L. X.; Raw, A.; Wu, L.; et al. FDA's New Pharmaceu- tical Quality Initiative: Knowledge-Aided Assessment & Structured Applications. Int. J. Pharm.: X 2019, 1, 100010. DOI: 10.1016/j.ijpx.2019.100010. 16. Lipa, M. J. Unlocking Knowledge to Benefit the Pa- tient: How Connecting KM and QRM Can Strengthen Science and Risk-Based Decision Making. Ph.D. The- sis, Technological University Dublin, Dublin, Ireland, 2021. 17. Wikipedia, Knowledge Industries. en.wikipedia.org/ wiki/Knowledge_industries (accessed June 04, 2022). 18. Lipa, M. J.; O'Donnell, K.; Greene, A. A Survey Report on the Current State of Quality Risk Management (QRM) and Knowledge Management (KM) Integration. Level 3 2021, 15 (3), 5. DOI: 10.21427/rpc7-sp95 19. Lipa, M. J.; O'Donnell, K.; Greene, A. Knowledge as the Currency of Managing Risk: A Novel Frame- work to Un ite Qua l it y R isk Ma nagement a nd Knowledge Management. Level 3 2020, 15 (2), 4. DOI: 10.21427/4mzp-vn67 20. Lipa, M. J.; Mulholland, V.; Greene, A. Integrating Knowledge Management and Quality Risk Manage- ment. ISPE Pharmaceutical Engineering 2022, 42 (4), 14–23. 21. APQC, Knowledge Management Capability Assess- ment Tool. www.apqc.org (accessed April 23, 2023). 22. Browning, T. R.; Ramasesh, R. V. Reducing Unwel- come Surprises in Project Management. MIT Sloan Manag Rev 2015, 56 (3), 53–62. 23. Mulholland, V.; Greene, A.; Lipa, M. J. Steps Beyond Risk Assessment in QRM: RBDM, the Next Horizon. Level 3 2021, 16 (1), 2. 24. APQC, The Pharmaceutical Process Classification Frame- work; APQC: Houston, Texas, 2008. https://www.apqc. org/system/files/PCF_Pharm_Ver_5.0.1.pdf. ■ Somnath Mishra, President, Shabas Solutions LLC FDA Quality Management Maturity (QMM) Overseas Pilot Program Findings: Going Beyond the Regulations In this episode of the Drug Solutions Podcast, Chris Spivey interviews exec- utives at Shabas Solutions LLC, who ran the overseas QMM pilot project. FDA mentioned QMM in its 2019 report, Drug Shortages: Root Causes and Potential Solutions, which pointed to a lack of manufacturer incentives to improve their quality management beyond the minimum required for cur- rent good manufacturing practice (CGMP) compliance. In this podcast, learn what QMM is, and how far beyond GMP functions QMM will drill into, and what accountability senior management bears for sustaining a corporate quality management culture, from an interview with executives at Shabas Solutions LLC, who ran the overseas pilot program. For more podcast episodes, visit our website! Zachary Royal, Senior Consultant, Shabas Solutions LLC Robert Michalik, Advisor, Quality and Corporate Compliance, Shabas Solutions LLC William Hauck, Senior Associate, Shabas Solutions LLC Clyde Schultz, Senior Associate, Shabas Solutions LLC

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - January 2024 - Pharmaceutical Technology - January 2024